IOVA

#4020
Iovance Biotherapeutics, Inc. Common Stock
3.86
+7.82%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
3.86
3.88
Jahresspanne
1.64
4.58
Tagesänderung
+7.82%
Monatliche Änderung
+28.67%
6 month change
+58.20%
Jahresänderung
-1.78%
Vorheriger Schlusskurs
3.58
Open
3.86
Bid
Ask
Low
3.86
High
3.88
Volumen
348
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.38 M
  • Employee 838
  • Founded 2007
  • CEO N/A
  • Website www.iovance.com
  • Headquarter Delaware, United States
  • FIGI BBG000FTLBV7
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.5
Price to sales ratio
0
Dividends per share
—
Dividend yield %
—

Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

Nachrichten